Leukemia, and Its Treatment, May Pose Neurocognitive Risks
FRIDAY, April 6, 2018 -- Underlying leukemia, even before chemotherapy, may pose a neurocognitive risk to young patients, according to a study published online March 29 in JAMA Oncology.
Yin Ting Cheung, Ph.D., from the St. Jude Children ' s Research...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Brain | Cancer & Oncology | Chemotherapy | Children | Leukemia | Neurology | Pharmaceuticals | Study